Advertise
Essential Formulas
Bluebonnet

Click Here for the Latest Episode of the Vitamin Professor Podcast Hosted by Gene Bruno

7-hydroxymitragynine


FDA and DOJ Seize 7-OH Products in Missouri

by Eric Munson | January 5, 2026

In December 2025, the U.S Food and Drug Administration (FDA) and the U.S. Department of Justice (DOJ) seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at about $1 million—from three firms in Missouri. The seizure focused on foods and dietary supplements products—including liquid shots and tablets—that contain 7-OH as an ingredient. Concentrated 7-OH has been ...

Florida Attorney General Files Emergency Rule on 7-OH Products

by Eric Munson | August 18, 2025

  On Aug. 13, Florida Attorney General James Uthmeier filed an emergency rule to classify isolated and/or concentrated 7-hydroxymitragynine (7-OH) products as a Schedule I controlled substance in Florida. The rule takes effect immediately and makes it illegal to sell, possess or distribute any isolated form of 7-OH in the state. The announcement comes a ...

FDA Takes Steps to Restrict 7-OH Opioid Products

by Eric Munson | August 4, 2025

On July 29, the U.S. Food and Drug Administration (FDA) took “bold steps” to protect American consumers from dangerous illegal opioids. The agency recommended a scheduling action to control certain 7-hydroxymitragyine (7-OH) products under the Controlled Substances Act. According to FDA, 7-OH is increasingly recognized for numerous health and safety issues because of its ability ...

FDA Issues Warning Letters on Products Containing 7-OH

by Eric Munson | July 21, 2025

On July 15, the U.S. Food and Drug Administration (FDA) announced it sent seven warning letters to companies for “illegally marketing” products containing 7-hydroxymitragynine (7-OH). According to FDA, there is growing concern around “novel potent opioid products” that are being marketed and sold online and in smoke shops, gas stations and corner stores. 7-OH is ...

DEA Postpones Ban on Kratom

by Nicholas Saraceno | October 17, 2016

On August 31, 2016, the Drug Enforcement Administration (DEA) published in the Federal Register a notice of intent to temporarily place mitragynine and 7-hydroxymitragynine, which are the main psychoactive constituents of the plant Mitragyna speciosa, also referred to as kratom, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. Since ...

Don't Miss Out!

Sign up for Vitamin Retailer Digital Newsletter
Digital Newsletter
Subscribe to Vitamin Retailer Magazine
Vitamin Retailer Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listing:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!